Where does Exactech, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Exactech, Inc. ranks #9,250 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Exactech, Inc. hold?

Exactech, Inc. holds 34 US utility patents granted between 2016 and 2025, spanning 4 technology areas.

What is Exactech, Inc.'s Innovation Score?

Exactech, Inc. has an Innovation Score of 39.7 out of 100 (top 37% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Exactech, Inc.'s patent grant rate increasing or decreasing?

Exactech, Inc.'s recent grant velocity is +111% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Exactech, Inc.'s patents?

Exactech, Inc.'s patents average 15.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Exactech, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Exactech, Inc.

Q: What technology areas does Exactech, Inc. focus on?

Exactech, Inc.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 25 patents, ranking #260 of 3,082 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 34 granted patents across 4 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Exactech ranks #9,250 of 49,997 tracked US assignees by granted-patent volume, with 34 patents across 4 technology areas.

#9,250
of 49,997 US assignees by volume: Top 37%
by Innovation Score (39.7/100): 15.4
avg claims per patent: +111%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9250 · US Corporation #9,250 · 34 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 34 grants
UPPER-Q #9,250/49,997
PHOTO-FINISH E F Johnson
CPC-NARROW A61F · 4 areas
INNOV-THIN 39.7/100
CLAIMS-RICH 15.4 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +111% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: E.F. Johnson Company (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Exactech’s 39.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.3 pts (31%) Velocity 11.1 pts (28%) Breadth 7.1 pts (18%) Claim depth 9.2 pts (23%)

Qualcomm Incorporated · highest

85
Abivax · near

40
Exactech · this assignee

40
Schleifring · near

40
Zealand Pharma A/S · near

40
OIL States Energy… · near

40
3D Lighting… · lowest

7

What this shows Exactech's Innovation Score is 39.7/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Exactech?

Each dot is one of Exactech’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Exactech’s own 15.4 claims/patent is at or below the 16.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Exactech vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Exactech's grants concentrate

Exactech, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 73.5% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2023 (6 grants) versus a trough of 1 in 2020. By volume, Exactech sits between E.F. Johnson Company and Flowco Production Solutions, LLC.

Exactech's three-year grant acceleration

Exactech, Inc. shows 15 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

E F Johnson

34
Everready Precisi…

34
Enduvo

34
Equity Shift

34
Excel Industries

34
FAM

34
FK Irons

34
Flowco Production…

34
Exactech ◀

34

What this shows Exactech holds 34 patents at rank #9,250, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Exactech

By rank, the assignees closest to #9,250 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Exactech's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Exactech, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Exactech ranks #260 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (40 here).

Abivax 40 Schleifring GmbH 40 Zealand Pharma A/S 40 OIL States Energy Services, L.L.C. 40

Exactech's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 37% higher than 63% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Exactech, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	4	11.8%
2019	5	14.7%
2020	1	2.9%
2021	3	8.8%
2022	4	11.8%
2023	6	17.6%
2024	5	14.7%
2025partial year	6	17.6%

Which technologies does Exactech, Inc. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 25

A61B - DIAGNOSIS; SURGERY; Identification 24

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

G06N - Computing Arrangements Based ON Specific Computational Models 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Exactech, Inc.'s patent record in context - here's where to go next.

Exactech, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 73.5% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #9,250 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Exactech, Inc. against E.F. Johnson Company, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.